Science Explorer Back to mapMap
Discussion
Company · Worcester · United States

ECI Biotech (United States)

Research works
58
▲ 266% vs 2018-21
Citations
3.5k
60.5 per fractional work
Top-10% rate
11.2%
all institutions 10.0%
Open access
28%
world 40%
International
13%
world 18%

Not ranked overall: ECI Biotech (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ECI Biotech (United States) work in?

In all years, 68% of research at ECI Biotech (United States) is in Life Sciences, 27% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (33%), Immunology and Microbiology (27%), Medicine (25%). It does 3.6× the world's share of Life Sciences.

Life Sciences: 39 fractional works · 67.7% of its workBiochemistry, Genetics and Molecular Biology: 19 fractional works · 32.7% of its workMolecular Biology: 14 fractional works · 24.3% of its workBiotechnology: 2 fractional works · 2.9% of its workGenetics: 1 fractional works · 2.0% of its workCell Biology: 1 fractional works · 1.3% of its workPhysiology: 1 fractional works · 1.1% of its workCancer Research: 1 fractional works · 0.9% of its workEndocrinology: 0 fractional works · 0.3% of its workImmunology and Microbiology: 15 fractional works · 26.7% of its workImmunology: 10 fractional works · 16.6% of its workVirology: 3 fractional works · 5.9% of its workParasitology: 2 fractional works · 3.4% of its workMicrobiology: 0 fractional works · 0.6% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 3 fractional works · 5.9% of its workEcology, Evolution, Behavior and Systematics: 2 fractional works · 2.6% of its workAgronomy and Crop Science: 1 fractional works · 1.8% of its workInsect Science: 0 fractional works · 0.9% of its workPlant Science: 0 fractional works · 0.6% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.7% of its workPharmaceutical Science: 1 fractional works · 1.2% of its workPharmacology: 0 fractional works · 0.6% of its workNeuroscience: 0 fractional works · 0.7% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.3% of its workBiological Psychiatry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Sciences: 15 fractional works · 26.6% of its workMedicine: 15 fractional works · 25.3% of its workInfectious Diseases: 3 fractional works · 5.3% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 4.6% of its workOncology: 2 fractional works · 3.1% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.5% of its workEpidemiology: 1 fractional works · 2.2% of its workSurgery: 1 fractional works · 1.5% of its workPulmonary and Respiratory Medicine: 1 fractional works · 0.9% of its workBiochemistry: 0 fractional works · 0.9% of its workPathology and Forensic Medicine: 0 fractional works · 0.8% of its workPhysiology: 0 fractional works · 0.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.6% of its workReproductive Medicine: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.6% of its workVeterinary: 0 fractional works · 0.8% of its workSmall Animals: 0 fractional works · 0.8% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.2% of its workPhysical Sciences: 3 fractional works · 5.5% of its workChemistry: 2 fractional works · 3.1% of its workOrganic Chemistry: 1 fractional works · 1.7% of its workAnalytical Chemistry: 0 fractional works · 0.6% of its workSpectroscopy: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 1 fractional works · 1.9% of its workBiomedical Engineering: 1 fractional works · 1.9% of its workMaterials Science: 0 fractional works · 0.6% of its workBiomaterials: 0 fractional works · 0.6% of its workSocial Sciences: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.2% of its workEconomics and Econometrics: 0 fractional works · 0.2% of its workALL ITS WORKECI Biotech(United States)58fractional works, all years
Life Sciences68%Physical Sciences6%Health Sciences27%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1932.7%
    2. Immunology and Microbiology1526.7%
    3. Agricultural and Biological Sciences35.9%
    4. Pharmacology, Toxicology and Pharmaceutics11.7%
    5. Neuroscience00.7%
    1. Medicine1525.3%
    2. Veterinary00.8%
    3. Nursing00.3%
    4. Health Professions00.2%
    1. Chemistry23.1%
    2. Engineering11.9%
    3. Materials Science00.6%
    1. Economics, Econometrics and Finance00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at ECI Biotech (United States)?

Ranked on the quality score, Charlotte Read Kensil, Cheryl Isaac Murphy and Joanne Recchia lead among researchers whose main affiliation is ECI Biotech (United States).

  1. 1 Charlotte Read Kensil United States · #818,757 worldwide 3.7k citations · 50 works
  2. 2 Cheryl Isaac Murphy United States · #1,244,256 worldwide 3.1k citations · 27 works
  3. 3 Joanne Recchia United States · #1,863,278 worldwide 1.1k citations · 15 works
  4. 4 Richard T. Coughlin United States · #2,352,399 worldwide 1.9k citations · 43 works
All ranked researchers at ECI Biotech (United States)

What are the most cited papers from ECI Biotech (United States)?

The most cited paper from ECI Biotech (United States) is "Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex" (Charlotte Read Kensil, Urmila H. Patel, Michael Lennick et al., 1991), with 655 citations. Next come "The tiny eukaryote Ostreococcus provides genomic insights into the paradox of plankton speciation" (645) and "Saponins as vaccine adjuvants." (296).

Most cited papers
#PaperReleasedCitations
1 Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex Charlotte Read Kensil, Urmila H. Patel, Michael Lennick et al. · The Journal of Immunology 1991 655
2 The tiny eukaryote Ostreococcus provides genomic insights into the paradox of plankton speciation Brian P. Palenik et al. · Proceedings of the National Academy of Sciences Open access 26 Apr 2007 645
3 Saponins as vaccine adjuvants. Kensil Cr · PubMed 1996 296
4 Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine Jiayan Wu, B H Gardner, Cheryl Isaac Murphy et al. · The Journal of Immunology Mar 1992 241
5 Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses Mark J. Newman, Jiayan Wu, B H Gardner et al. · The Journal of Immunology Apr 1992 224
All 94 most cited papers, with filters and sorting

Which keywords describe research at ECI Biotech (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Cancer, Glycosylation, Antioxidant, Apoptosis, Immune Response, Vaccine and Cancer Therapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology10▲ 4.4×22 topics
  2. Cancer7▲ 8.2×10 topics
  3. Antioxidant4▲ 11×8 topics
  4. Glycosylation4▲ 35×3 topics
  5. Apoptosis4▲ 19×6 topics
  6. Immune Response4▲ 12×6 topics
  7. Cancer Therapy4▲ 12×7 topics
  8. Vaccine4▲ 18×6 topics
  9. Antiretroviral Therapy4▲ 28×4 topics
  10. Antiviral4▲ 70×2 topics
  11. Public Health4▲ 4.7×3 topics
  12. Anti-inflammatory4▲ 22×2 topics
  13. Biological Activities4▲ 32×2 topics
  14. Immune Activation4▲ 67×2 topics
  15. Antibodies4▲ 69×2 topics
  16. HIV4▲ 51×2 topics
  17. AIDS3▲ 113×1 topic
  18. Pathogenesis3▲ 11×5 topics
  19. Saponins3▲ 124×1 topic
  20. Triterpenoids3▲ 92×1 topic
  21. neurocognitive disorders3▲ 113×1 topic
  22. Targeted Therapy3▲ 24×2 topics
  23. Immunotoxin3▲ 161×1 topic
  24. Ricin Poisoning3▲ 161×1 topic
  25. Immunotherapy3▲ 6.8×7 topics
  26. Genetic Characterization2▲ 71×2 topics
  27. Biopharmaceutical Production2▲ 50×2 topics
  28. Host-Pathogen Interactions2▲ 38×2 topics
  29. Biopharmaceuticals2▲ 55×2 topics
  30. Recombinant Proteins2▲ 70×2 topics
  31. Immunity2▲ 11×5 topics
  32. Infection2▲ 13×3 topics
  33. Cell Culture2▲ 31×2 topics
  34. Leukemia2▲ 53×2 topics
  35. Lymphoma2▲ 23×2 topics
  36. Pathogen Transmission2▲ 53×2 topics
  37. Immune System2▲ 10×2 topics
  38. Lyme Disease2▲ 112×1 topic
  39. Therapeutics2▲ 23×2 topics
  40. Tick-Borne Diseases2▲ 112×1 topic

Which research topics does ECI Biotech (United States) publish most on?

By volume in 2022-now: Corneal Surgery and Treatments, Corneal surgery and disorders, Ocular Surface and Contact Lens and Biomedical Ethics and Regulation.

  1. 1 Corneal Surgery and Treatments Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Corneal surgery and disorders Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 1 works
  4. 4 Biomedical Ethics and Regulation Physiology 0 works
  5. 5 CAR-T cell therapy research Oncology 0 works
  6. 6 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  7. 7 Ocular Disorders and Treatments Genetics 0 works
  8. 8 Adenosine and Purinergic Signaling Physiology 0 works
  9. 9 Phytochemicals and Antioxidant Activities Biochemistry 0 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.9%not open72.1%

World: 40% of research is openly available.

with international co-authors13.4%domestic only86.6%

World: 18% is written across borders.

How has ECI Biotech (United States)'s research output changed?

Output in 2022-2025 was 266% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is ECI Biotech (United States) as a percentage of every work published that year, 0.000012% in 2024.

still counting0.00050%0.0010%ECI Biotech (United States)0.000028% in 20251990200020102020

Fractional works of ECI Biotech (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Worcester

All research institutions in Worcester

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ECI Biotech (United States). Posts are plain text and can be reported.